Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Palliative care delivery according to age in 12,000 women with metastatic breast cancer: Analysis in the multicentre ESME-MBC cohort 2008-2016.
Frasca M, Sabathe C, Delaloge S, Galvin A, Patsouris A, Levy C, Mouret-Reynier MA, Desmoulins I, Vanlemmens L, Bachelot T, Goncalves A, Perotin V, Uwer L, Frenel JS, Ferrero JM, Bouleuc C, Eymard JC, Dieras V, Leheurteur M, Petit T, Dalenc F, Jaffre A, Chevrot M, Courtinard C, Mathoulin-Pelissier S. Frasca M, et al. Among authors: bouleuc c. Eur J Cancer. 2020 Sep;137:240-249. doi: 10.1016/j.ejca.2020.07.007. Epub 2020 Aug 14. Eur J Cancer. 2020. PMID: 32805641
Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer.
Alderman B, Hui D, Mukhopadhyay S, Bouleuc C, Case AA, Amano K, Crawford GB, de Feo G, Sbrana A, Tanco K, To J, Garsed J, Davis M. Alderman B, et al. Among authors: bouleuc c. Support Care Cancer. 2022 Dec 16;31(1):39. doi: 10.1007/s00520-022-07480-x. Support Care Cancer. 2022. PMID: 36525085 Review.
Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: the observational step of the CirCe01 phase III trial.
Helissey C, Berger F, Cottu P, Diéras V, Mignot L, Servois V, Bouleuc C, Asselain B, Pelissier S, Vaucher I, Pierga JY, Bidard FC. Helissey C, et al. Among authors: bouleuc c. Cancer Lett. 2015 May 1;360(2):213-8. doi: 10.1016/j.canlet.2015.02.010. Epub 2015 Feb 17. Cancer Lett. 2015. PMID: 25700777 Clinical Trial.
PALLIA-10, a screening tool to identify patients needing palliative care referral in comprehensive cancer centers: A prospective multicentric study (PREPA-10).
Molin Y, Gallay C, Gautier J, Lardy-Cleaud A, Mayet R, Grach MC, Guesdon G, Capodano G, Dubroeucq O, Bouleuc C, Bremaud N, Fogliarini A, Henry A, Caunes-Hilary N, Villet S, Villatte C, Frasie V, Triolaire V, Barbarot V, Commer JM, Hutin A, Chvetzoff G. Molin Y, et al. Among authors: bouleuc c. Cancer Med. 2019 Jun;8(6):2950-2961. doi: 10.1002/cam4.2118. Epub 2019 May 4. Cancer Med. 2019. PMID: 31055887 Free PMC article.
A phase III randomized trial of weight loss to reduce cancer-related fatigue among overweight and obese breast cancer patients: MEDEA Study design.
Di Meglio A, Martin E, Crane TE, Charles C, Barbier A, Raynard B, Mangin A, Tredan O, Bouleuc C, Cottu PH, Vanlemmens L, Segura-Djezzar C, Lesur A, Pistilli B, Joly F, Ginsbourger T, Coquet B, Pauporte I, Jacob G, Sirven A, Bonastre J, Ligibel JA, Michiels S, Vaz-Luis I. Di Meglio A, et al. Among authors: bouleuc c. Trials. 2022 Mar 4;23(1):193. doi: 10.1186/s13063-022-06090-6. Trials. 2022. PMID: 35246219 Free PMC article. Clinical Trial.
Impact of early palliative care on additional line of chemotherapy in metastatic breast cancer patients: results from the randomized study OSS.
Chvetzoff G, Bouleuc C, Lardy-Cléaud A, Saltel P, Dieras V, Morelle M, Guastalla JP, Tredan O, Rebattu P, Pop S, Ray-Coquard I, Pierga JY, Mignot L, Laurence V, Bourne-Branchu V, Pérol D, Bachelot T. Chvetzoff G, et al. Among authors: bouleuc c. Support Care Cancer. 2022 Dec 27;31(1):82. doi: 10.1007/s00520-022-07561-x. Support Care Cancer. 2022. PMID: 36574052 Clinical Trial.
High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults.
Lotz JP, André T, Donsimoni R, Firmin C, Bouleuc C, Bonnak H, Merad Z, Esteso A, Gerota J, Izrael V. Lotz JP, et al. Among authors: bouleuc c. Cancer. 1995 Feb 1;75(3):874-85. doi: 10.1002/1097-0142(19950201)75:3<874::aid-cncr2820750320>3.0.co;2-q. Cancer. 1995. PMID: 7828139 Clinical Trial.
73 results